We have developed a technology that brings together electronically active s
emiconductor chips with biomedical assays or tests. By creating an array of
electrodes that can be individually addressed, it is possible to manipulat
e DNA and other biological molecules to perform bioassays in a number of di
fferent formats. Recently, we have fabricated and tested chips that support
independent, electronically driven reactions at 400 or more sites. To cont
rol these sites, we have utilized a CMOS architecture which incorporates ro
w and column addressing, and active current control and self-test at each s
ite. We have developed an electronically driven hybridization assay for an
application in genetic identification that takes advantage of the large num
ber of available assay locations. To perform the assay, sample DNA is elect
rophoretically propelled and hybridized to an immobilized DNA probe on the
chip and to a fluorophore-labeled DNA probe in solution. Detection of a pos
itive assay result depends on light emitted by the fluorophore-labeled prob
e in a hybridization complex that also contains the immobilized capture pro
be and the sample DNA. The fluorophore is excited by light from a diode las
er, which is coupled into the chip by a unique cartridge design that incorp
orates a polymer waveguide for dark field illumination. The light emitted b
y fluorophores is detected by a CCD camera. The present generation of chips
will potentially enable a wide range of applications including genetic ide
ntification tests, detection of bacteria and other infectious agents, assay
s for genetic diseases, examination of the products of many genes and scree
ning for potential drugs. (C) 2000 Elsevier Science S.A. All rights reserve
d.